Longitudinal analysis of simian immunodeficiency virus (SIV) replication in the lungs: Compartmentalized regulation of SIV

Journal of Infectious Diseases

Volumn 194, Issue 7, 2006, Pages 931-938

  Barber, Sheila A ^a   Gama, Lucio ^a   Li, Ming ^a   Voelker, Tauni ^a   Anderson, John E ^a   Zink, M Christine ^a   Tarwater, Patrick M ^c   Carruth, Lucy M ^b   Clements, Janice E ^a,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Cylex Incorporated   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d BRB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CCAAT ENHANCER BINDING PROTEIN BETA; CD14 ANTIGEN; ISOPROTEIN; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DNA DETERMINATION; GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LATENT VIRUS INFECTION; LONGITUDINAL STUDY; LUNG ALVEOLUS MACROPHAGE; LUNG INFECTION; LUNG LAVAGE; LUNG PARENCHYMA; MACACA; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION; WESTERN BLOTTING;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; DNA, VIRAL; HUMANS; LUNG; MACACA NEMESTRINA; MACROPHAGES, ALVEOLAR; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

EID: 33749024754     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/507429     Document Type: Article

References (43)

1. Afessa B, Green W, Chiao J, Frederick W. Pulmonary complications of HIV infection: autopsy findings. Chest 1998; 113:1225-9.
2. Masliah E, DeTeresa RM, Mallory ME, Hansen LA. Changes in pathological findings at autopsy in AIDS cases for the last 15 years. AIDS 2000; 14:69-74.
3. Baskin GB, Murphey-Corb M, Martin LN, Soike KF, Hu FS, Kuebler D. Lentivirus-induced pulmonary lesions in rhesus monkeys (Macaca mulatta) infected with simian immunodeficiency virus. Vet Pathol 1991; 28:506-13.
4. Mankowski JL, Carter DL, Spelman JP, et al. Pathogenesis of simian immunodeficiency virus pneumonia: an immunopathological response to virus. Am J Pathol 1998; 153:1123-30.
5. Schuitemaker H, Kootstra NA, Groenink M, De Goede RE, Miedema F, Tersmette M. Differential tropism of clinical HIV-1 isolates for primary monocytes and promonocytic cell lines. AIDS Res Hum Retroviruses 1992; 8:1679-82.
6. van't Wout AB, Ran LJ, Kuiken CL, Kootstra NA, Pals ST, Schuitemaker H. Analysis of the temporal relationship between human immunodeficiency virus type 1 quasispecies in sequential blood samples and various organs obtained at autopsy. J Virol 1998; 72:488-96.
7. Agostini C, Trentin L, Zambello R, Semenzato G. HIV-1 and the lung: infectivity, pathogenic mechanisms, and cellular immune responses taking place in the lower respiratory tract. Am Rev Respir Dis 1993; 147:1038-49.
8. Lebargy F, Branellec A, Deforges L, Bignon J, Bernaudin JF. HIV-1 in human alveolar macrophages from infected patients is latent in vivo but replicates after in vitro stimulation. Am J Respir Cell Mol Biol 1994; 10:72-8.
9. Hoshino Y, Nakata K, Hoshino S, et al. Maximal HIV-1 replication in alveolar macrophages during tuberculosis requires both lymphocyte contact and cytokines. J Exp Med 2002; 195:495-505.
10. Gold JA, Hoshino Y, Tanaka N, et al. Surfactant protein A modulates the inflammatory response in macrophages during tuberculosis. Infect Immun 2004; 72:645-50.
11. Rich EA. Activation-inactivation of HIV-1 in the lung. J Biomed Sci 1998; 5:1-10.
12. Nakata K, Weiden M, Harkin T, Ho D, Rom WN. Low copy number and limited variability of proviral DNA in alveolar macrophages from HIV-1-infected patients: evidence for genetic differences in HIV-1 between lung and blood macrophage populations. Mol Med 1995; 1:744-57.
13. Sierra-Madero JG, Toossi Z, Hom DL, Finegan CK, Hoenig E, Rich EA. Relationship between load of virus in alveolar macrophages from human immunodeficiency virus type 1-infected persons, production of cytokines, and clinical status. J Infect Dis 1994; 169:18-27.
14. Nakata K, Rom WN, Honda Y, et al. Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung. Am J Respir Crit Care Med 1997; 155:996-1003.
15. Honda Y, Rogers L, Nakata K, et al. Type I interferon induces inhibitory 16-kD CCAAT/enhancer binding protein (C/EBP)beta, repressing the HIV-1 long terminal repeat in macrophages: pulmonary tuberculosis alters C/EBP expression, enhancing HIV-1 replication. J Exp Med 1998; 188:1255-65.
16. Kornbluth RS, Oh PS, Munis JR, Cleveland PH, Richman DD. The role of interferons in the control of HIV replication in macrophages. Clin Immunol Immunopathol 1990; 54:200-19.
17. Descombes P, Schibler U. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 1991; 67:569-79.
18. Weiden M, Tanaka N, Qiao Y, et al. Differentiation of monocytes to macrophages switches the Mycobacterium tuberculosis effect on HIV-1 replication from stimulation to inhibition: modulation of interferon response and CCAAT/enhancer binding protein beta expression. J Immunol 2000; 165:2028-39.
19. Henderson AJ, Zou X, Calame KL. C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes. J Virol 1995; 69:5337-44.
20. Henderson AJ, Connor RI, Calame KL. C/EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines. Immunity 1996; 5:91-101.
21. + T cells. Proc Natl Acad Sci USA 1997; 94:8714-9.
22. Fuller CL, Choi YK, Fallert BA, Et al. Restricted SIV replication in rhesus macaque lung tissues during the acute phase of infection. Am J Pathol 2002; 161:969-78.
23. Canto-Nogues C, Jones S, Sangster R, et al. In situ hybridization and immunolabelling study of the early replication of simian immunodeficiency virus (SIVmacJ5) in vivo. J Gen Virol 2001; 82:2225-34.
24. Caufour P, Le Grand R, Cheret A, et al. Secretion of beta-chemokines by bronchoalveolar lavage cells during primary infection of macaques inoculated with attenuated nef-deleted or pathogenic simian immunodeficiency virus strain mac251. J Gen Virol 1999; 80 (Pt 3):767-76.
25. Zink MC, Suryanarayana K, Mankowski JL, et al. High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis. J Virol 1999; 73:10480-8.
26. Babas T, Vieler E, Hauer DA, et al. Pathogenesis of SIV pneumonia: selective replication of viral genotypes in the lung. Virology 2001; 287:371-81.
27. Carruth LM, Zink MC, Tarwater FM, et al. SIV-specific T lymphocyte responses in PBMC and lymphoid tissues of SIV-infected pigtailed macaques during suppressive combination antiretroviral therapy. J Med Primatol 2005; 34:109-21.
28. Barber SA, Gama L, Dudaronek JM, Voelker T, Tarwater PM, Clements JE. Mechanism for establishment of transcriptional HIV latency in the brain using an SIV macaque model. J Infect Dis 2006; 193:963-70.
29. Clements JE, Babas T, Mankowski JL, et al. The central nervous system as a reservoir for simian immunodeficiency virus (SIV): steady-state levels of SIV DNA in brain from acute through asymptomatic infection. J Infect Dis 2002; 186:905-13.
30. Barber SA, Herbst DS, Bullock BT, Gama L, Clements JE. Innate immune responses and control of acute simian immunodeficiency virus replication in the central nervous system. J Neurovirol 2004; 10(Suppl 1):15-20.
31. Zink MC, Coleman GD, Mankowski JL, et al. Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis. J Infect Dis 2001; 184:1015-21.
32. Gordon SB, Read RC. Macrophage defences against respiratory tract infections. Br Med Bull 2002; 61:45-61.
33. Kracke A, von Wussow P, Al-Masri AN, Dalley G, Windhagen A, Heidenreich F. Mx proteins in blood leukocytes for monitoring interferon beta-Ib therapy in patients with MS. Neurology 2000; 54:193-9.
34. Kanmogne GD. Noninfectious pulmonary complications of HIV/AIDS. Curr Opin Pulm Med 2005; 11:208-12.
35. Dore GJ, Correll PK, Li Y, Kaldor JM, Cooper DA, Brew BJ. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 1999; 13:1249-53.
36. Neuenburg JK, Brodt HR, Herndier BG, et al. HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 31:171-7.
37. Sacktor N, McDermott MP, Marder K, et al. HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol 2002; 8:136-42.
38. Williams KC, Corey S, Westmoreland SV, et al. Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J Exp Med 2001; 193:905-15.
39. Cosenza MA, Zhao ML, Si Q, Lee SC. Human brain parenchymal microglia express CD14 and CD45 and are productively infected by HIV-1 in HIV-1 encephalitis. Brain Pathol 2002; 12:442-55.
40. Korber BT, Kunstman KJ, Patterson BK, et al. Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J Virol 1994; 68:7467-81.
41. Babas T, Munoz D, Mankowski JL, Tarwater PM, Clements JE, Zink MC. Role of microglial cells in selective replication of simian immunodeficiency virus genotypes in the brain. J Virol 2003; 77:208-16.
42. Alimohammadi A, Coker R, Miller R, Mitchell D, Williamson J, Clarke J. Genotypic variants of HIV-1 from peripheral blood and lungs of AIDS patients. AIDS 1997; 11:831-2.
43. Itescu S, Simonelli PF, Winchester RJ, Ginsberg HS. Human immunodeficiency virus type 1 strains in the lungs of infected individuals evolve independently from those in peripheral blood and are highly conserved in the C-terminal region of the envelope V3 loop. Proc Natl Acad Sci USA 1994; 91:11378-82.